Joshua Cohen, MD, MPH, FAHS

Chief Medical Officer
Braeburn

Poster(s):

• (267) Post-launch adverse events reported to FDA adverse event reporting system for long-acting injectable buprenorphine
  Wednesday, October 29, 2025